SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001140361-07-013299
Filing Date
2007-07-02
Accepted
2007-07-02 16:33:32
Documents
1

Document Format Files

Seq Description Document Type Size
1 doc1.htm SC 13D 21814
  Complete submission text file 0001140361-07-013299.txt   23726
Mailing Address 1101 BRICKELL AVENUE SUITE 701 S MIAMI FL 33131
Business Address 1101 BRICKELL AVENUE SUITE 701 S MIAMI FL 33131 305-534-3383
DOR BIOPHARMA INC (Subject) CIK: 0000812796 (see all company filings)

IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-39976 | Film No.: 07955790
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1101 BRICKELL AVENUE SUITE 701-S MIAMI FL 33131
Business Address 786-425-3848
Buhrman Cyrille F (Filed by) CIK: 0001405103 (see all company filings)

Type: SC 13D